SC
TARO

Schubert & Co’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Schubert & Co’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$49 – 1628
2023
Q1 		$49 Buy
+2
New +$58 ﹤0.01% 1633
2022
Q4 		– Sell
-2
Closed – – 1653
2022
Q3 		$0 Buy
+2
New +$69 ﹤0.01% 1633
2022
Q2 		– Sell
-2
Closed – – 1636
2022
Q1 		$0 Buy
2
+1
+100% +$47 ﹤0.01% 1402
2021
Q4 		$0 Buy
+1
New +$56 ﹤0.01% 1351

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Schubert & Co's TARO Position: Q2 2023 in Review

Schubert & Co sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2023, closing a stake of 2 shares — an estimated $49 sold.

Schubert & Co first reported a position in TARO in Q4 2021 and held it in 4 quarters. The position peaked at $49 in Q1 2023. 71 funds tracked by Wall St. Rank hold TARO as of Q2 2023.

  • Schubert & Co reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 2 Taro Pharmaceutical Industries Ltd. shares in Q2 2023, an estimated $49.
  • Schubert & Co first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2021 and held it in 4 quarters.
  • Schubert & Co's Taro Pharmaceutical Industries Ltd. position peaked at $49 in Q1 2023.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.